MedGenome

MedGenome is a genomics and clinical-data-driven diagnostics and research company founded in 2013, with a focus on next-generation sequencing. It is headquartered in California and has a CAP-certified lab and research center in Bangalore, serving cancer, rare disease and prenatal testing.

Investment rationale 

MedGenome provides exposure to the expanding use of genomics in diagnostics, drug discovery and personalised medicine. Its testing capabilities and proprietary genomic data position the company to benefit from broader adoption of testing, research demand and healthcare needs across South Asia.

Headquarters: California, USA

Website: https://diagnostics.medgenome.com/ 

Responsible partner: Jannick Mortensen

Fund: MIM II